Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Brita Brown"'
Autor:
Paul M. Slattum, J. Adam Willardsen, Weston R Judd, Brita Brown, Liwen Huang, Daniel Wettstein, Kirill Ostanin, Khanh C. Hoang, Glen L Alberts, Bruce D. Roth, Burt Richards, Liisa Valppu, Leena Bhoite
Publikováno v:
Journal of Medicinal Chemistry. 54:5031-5047
A series of tetrahydropyranyl (THP) derivatives has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents. Structural modification of the submicromolar hit compound 3 led to the potent
Publikováno v:
Santé mentale au Québec. 34:217-235
Environ 50 % des aînés qui ont un problème de santé mentale ne reçoivent pas les services en lien avec leur situation. Le Projet PIE (Prévention-Intervention-Éducation), une stratégie de dépistage proactif mise sur l’implication des source
Autor:
Kaedi R. Garvin, Brita Brown, Bronwyn G. Hughes, Kim L. O'Neill, David P. Tomer, Philip M. Scherer, Byron K. Murray
Publikováno v:
Nutrition Research. 26:186-192
Recent studies have shown that retinoids and vitamin E are effective growth inhibitors of numerous cancer cell lines. In the present study, vitamin A derivative 13-cis-retinoic acid and α-tocopherol succinate were administered to HT-29 human colon a
Autor:
Ruth Ann Scroggs, Xiaoyan Zhan, Julia L. Hurwitz, Kelli L. Boyd, Cecilia Prouser, Sateesh Krishnamurthy, Allen Portner, Chris Coleclough, Brita Brown, Karen S. Slobod, Toru Takimoto
Publikováno v:
Viral Immunology. 18:255-266
Respiratory syncytial virus (RSV) is among the most important and serious pediatric respiratory diseases, and yet after more than four decades of research an effective vaccine is still unavailable. This review examines the role of the immune response
Autor:
Amy Zirkel, Brita Brown, Timothy D. Lockey, Julia L. Hurwitz, Peter C. Doherty, Robert E. Sealy, Karen S. Slobod, Xiaoyan Zhan, Pamela Freiden, Louis N. Martin, John Stambas, Bart G. Jones, Mattia Bonsignori, James Blanchard, Sherri L. Surman, Chris Coleclough, Scott A. Brown
Publikováno v:
Current HIV Research. 3:107-112
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences in envelope proteins result in distinct HIV serotypes, operationally defined such that antibodies raised against envelope molecules from one serotype w
Autor:
Xiaoyan Zhan, Julia L. Hurwitz, Sateesh Krishnamurthy, Toru Takimoto, Ruth Ann Scroggs, Cecilia Prouser, Brita Brown, Yoshiyuki Nagai, Allen Portner, Karen S. Slobod, Chris Coleclough, Kelli L. Boyd
Publikováno v:
Journal of Virology. 78:6043-6047
Although RSV causes serious pediatric respiratory disease, an effective vaccine does not exist. To capture the strengths of a live virus vaccine, we have used the murine parainfluenza virus type 1 (Sendai virus [SV]) as a xenogeneic vector to deliver
Autor:
Michèle Charpentier, Brita Brown
Publikováno v:
Vieillir au pluriel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48de37365ed924d50bb1bc7b321dc6f6
https://doi.org/10.2307/j.ctv18ph6h8.14
https://doi.org/10.2307/j.ctv18ph6h8.14
Publikováno v:
Sante mentale au Quebec. 34(2)
Approximately fifty percent of older adults with a mental health problem do not receive services. A proactive outreach strategy, Project PIE (Prevention-Intervention-Education) relies upon the assistance of non-traditional referral sources, namely co
Autor:
Robert E. Sealy, Timothy D. Lockey, Peter C. Doherty, Brita Brown, John Stambas, Astrid Gutierrez, Julia L. Hurwitz, Wen Yue, Karen S. Slobod, Sherri L. Surman, Christopher Coleclough, Scott A. Brown, Amy Zirkel, Pamela Freiden, Bart G. Jones
Publikováno v:
Vaccine. 23(19)
Despite decades of work, an effective HIV vaccine remains elusive. In an effort to elicit protective immunity, investigators have sought to define vaccines able to elicit durable HIV-specific B-cell and T-cell activities. Additionally, vaccines are s
Publikováno v:
Transplantation. 76(4)
Background Donor-derived, ex vivo-expanded cytotoxic T lymphocytes (CTL) can provide stem-cell transplantation (SCT) patients with a renewed capacity for virus-specific immune surveillance. Because SCT patients are often treated with cyclosporine (Cs